• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤源性 microRNAs 在肿瘤免疫逃逸中的作用。

The role of cancer-derived microRNAs in cancer immune escape.

机构信息

Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.

出版信息

J Hematol Oncol. 2020 Mar 28;13(1):25. doi: 10.1186/s13045-020-00848-8.

DOI:10.1186/s13045-020-00848-8
PMID:32222150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7103070/
Abstract

During malignant transformation, accumulated somatic mutations endow cancer cells with increased invasiveness and immunogenicity. Under selective pressure, these highly immunogenic cancer cells develop multiple strategies to evade immune attack. It has been well established that cancer cells could downregulate the expression of major histocompatibility complex, acquire alterations in interferon pathway, and upregulate the activities of immune checkpoint pathways. Besides, cancer cells secret numerous cytokines, exosomes, and microvesicles to regulate the functions and abundances of components in the tumor microenvironment including immune effector cells and professional antigen presentation cells. As the vital determinant of post-transcriptional regulation, microRNAs (miRNAs) not only participate in cancer initiation and progression but also regulate anti-cancer immune response. For instance, some miRNAs affect cancer immune surveillance and immune escape by interfering the expression of immune attack-associated molecules. A growing body of evidence indicated that cancer-derived immune modulatory miRNAs might be promising targets to counteract cancer immune escape. In this review, we summarized the role of some miRNAs in cancer immune escape and discussed their potential clinical application as treatment targets.

摘要

在恶性转化过程中,积累的体细胞突变赋予癌细胞更高的侵袭性和免疫原性。在选择压力下,这些高度免疫原性的癌细胞会发展出多种策略来逃避免疫攻击。已经证实,癌细胞可以下调主要组织相容性复合体的表达,获得干扰素途径的改变,并上调免疫检查点途径的活性。此外,癌细胞分泌大量细胞因子、外泌体和微泡,以调节肿瘤微环境中包括免疫效应细胞和专业抗原呈递细胞在内的成分的功能和丰度。作为转录后调控的重要决定因素,microRNAs(miRNAs)不仅参与癌症的发生和发展,还调节抗肿瘤免疫反应。例如,一些 miRNAs 通过干扰与免疫攻击相关的分子的表达来影响癌症的免疫监视和免疫逃逸。越来越多的证据表明,源自癌症的免疫调节 miRNAs 可能是对抗癌症免疫逃逸的有前途的靶点。在这篇综述中,我们总结了一些 miRNAs 在癌症免疫逃逸中的作用,并讨论了它们作为治疗靶点的潜在临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c1/7103070/32c91d5fbb32/13045_2020_848_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c1/7103070/6377100ec260/13045_2020_848_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c1/7103070/0c12367e0baf/13045_2020_848_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c1/7103070/32c91d5fbb32/13045_2020_848_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c1/7103070/6377100ec260/13045_2020_848_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c1/7103070/0c12367e0baf/13045_2020_848_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c1/7103070/32c91d5fbb32/13045_2020_848_Fig3_HTML.jpg

相似文献

1
The role of cancer-derived microRNAs in cancer immune escape.肿瘤源性 microRNAs 在肿瘤免疫逃逸中的作用。
J Hematol Oncol. 2020 Mar 28;13(1):25. doi: 10.1186/s13045-020-00848-8.
2
Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape.参与肿瘤攻击和肿瘤免疫逃逸的免疫调节 microRNAs。
J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx034.
3
The emerging role of miRNA in the perturbation of tumor immune microenvironment in chemoresistance: Therapeutic implications.miRNA 在肿瘤免疫微环境化疗耐药性改变中的新兴作用:治疗意义。
Semin Cell Dev Biol. 2022 Apr;124:99-113. doi: 10.1016/j.semcdb.2021.04.001. Epub 2021 Apr 15.
4
Immune modulatory microRNAs as a novel mechanism to revert immune escape of tumors.免疫调节 microRNAs 作为一种逆转肿瘤免疫逃逸的新机制。
Cytokine Growth Factor Rev. 2017 Aug;36:49-56. doi: 10.1016/j.cytogfr.2017.07.001. Epub 2017 Jul 13.
5
Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art.癌症衍生的外泌体微小RNA塑造肿瘤微环境中的免疫系统:最新进展
Semin Cell Dev Biol. 2017 Jul;67:23-28. doi: 10.1016/j.semcdb.2016.12.004. Epub 2016 Dec 9.
6
Investigation of miRNA dysregulation and association with immune cell profile during malignant transformation of colorectal cells.结直肠细胞恶性转化过程中miRNA失调及其与免疫细胞谱相关性的研究。
Eur J Surg Oncol. 2022 Jan;48(1):245-252. doi: 10.1016/j.ejso.2021.09.016. Epub 2021 Sep 30.
7
Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression.肿瘤免疫微环境及其相关 miRNAs 在肿瘤进展中的作用。
Front Immunol. 2021 May 18;12:624725. doi: 10.3389/fimmu.2021.624725. eCollection 2021.
8
The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies.miRNA 在肿瘤免疫逃逸中的作用及基于 miRNA 的治疗策略。
Front Immunol. 2022 Jan 18;12:807895. doi: 10.3389/fimmu.2021.807895. eCollection 2021.
9
Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy.肿瘤中的免疫调节 microRNAs,其在诊断和治疗中的临床相关性。
J Immunother Cancer. 2024 Aug 29;12(8):e009774. doi: 10.1136/jitc-2024-009774.
10
Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment.癌症中的免疫调节 microRNAs:靶向免疫检查点和肿瘤微环境。
FEBS J. 2019 Sep;286(18):3540-3557. doi: 10.1111/febs.15000. Epub 2019 Jul 27.

引用本文的文献

1
CircRNA in non‑small cell lung cancer: Potential biomarkers and therapeutic targets (Review).非小细胞肺癌中的环状RNA:潜在的生物标志物和治疗靶点(综述)
Mol Med Rep. 2025 Nov;32(5). doi: 10.3892/mmr.2025.13662. Epub 2025 Aug 29.
2
Urinary microRNAs as Prognostic Biomarkers for Predicting the Efficacy of Immune Checkpoint Inhibitors in Patients with Urothelial Carcinoma.尿微小RNA作为预测尿路上皮癌患者免疫检查点抑制剂疗效的预后生物标志物
Cancers (Basel). 2025 Aug 13;17(16):2640. doi: 10.3390/cancers17162640.
3
The regulatory role and mechanism of energy metabolism and immune response in head and neck cancer.

本文引用的文献

1
Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer.工程化外泌体实现 miR-21 抑制剂和化疗药物的靶向共递送,逆转结肠癌的耐药性。
J Nanobiotechnology. 2020 Jan 9;18(1):10. doi: 10.1186/s12951-019-0563-2.
2
MicroRNAs that predict the effectiveness of anti-PD-1 therapies in patients with advanced melanoma.可预测晚期黑色素瘤患者抗程序性死亡蛋白1(PD-1)疗法疗效的微小RNA
J Dermatol Sci. 2020 Jan;97(1):77-79. doi: 10.1016/j.jdermsci.2019.11.010. Epub 2019 Nov 30.
3
Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells.
能量代谢与免疫反应在头颈癌中的调控作用及机制
Genes Dis. 2025 Mar 19;12(6):101607. doi: 10.1016/j.gendis.2025.101607. eCollection 2025 Nov.
4
MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer.微小RNA-200a调控程序性死亡受体配体1,并预测晚期非小细胞肺癌对免疫检查点抑制剂的反应。
Transl Lung Cancer Res. 2025 Jul 31;14(7):2522-2536. doi: 10.21037/tlcr-2025-117. Epub 2025 Jul 28.
5
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches.癌症中的免疫逃逸:机制与前沿治疗方法。
Signal Transduct Target Ther. 2025 Jul 31;10(1):227. doi: 10.1038/s41392-025-02280-1.
6
MicroRNAs in Cancer Immunology: Master Regulators of the Tumor Microenvironment and Immune Evasion, with Therapeutic Potential.癌症免疫学中的微小RNA:肿瘤微环境和免疫逃逸的主要调节因子,具有治疗潜力。
Cancers (Basel). 2025 Jun 27;17(13):2172. doi: 10.3390/cancers17132172.
7
Recent research advances in interleukin, microRNA and neuroendocrine tumor biomarkers (Review).白细胞介素、微小RNA与神经内分泌肿瘤生物标志物的最新研究进展(综述)
Mol Clin Oncol. 2025 Jun 17;23(2):71. doi: 10.3892/mco.2025.2866. eCollection 2025 Aug.
8
Hydrogels as Suitable miRNA Delivery Systems: A Review.水凝胶作为合适的miRNA递送系统:综述
Polymers (Basel). 2025 Mar 28;17(7):915. doi: 10.3390/polym17070915.
9
Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers.靶向PD-1/PD-L1信号通路用于癌症治疗:聚焦生物标志物。
Int J Mol Sci. 2025 Jan 31;26(3):1235. doi: 10.3390/ijms26031235.
10
Oral Cancer-Derived miR-762 Suppresses T-Cell Infiltration and Activation by Horizontal Inhibition of CXCR3 Expression.口腔癌来源的miR-762通过水平抑制CXCR3表达抑制T细胞浸润和激活。
Int J Mol Sci. 2025 Jan 26;26(3):1077. doi: 10.3390/ijms26031077.
环状 RNA circFGFR1 通过海绵吸附 miR-381-3p 促进非小细胞肺癌细胞的进展和抗 PD-1 耐药性。
Mol Cancer. 2019 Dec 9;18(1):179. doi: 10.1186/s12943-019-1111-2.
4
Identification of a -Fas ligand axis in the development of neutropenia in T large granular lymphocyte leukemia.鉴定 T 大颗粒淋巴细胞白血病中性粒细胞减少症发病机制中的 Fas 配体轴。
Haematologica. 2020 May;105(5):1351-1360. doi: 10.3324/haematol.2019.225060. Epub 2019 Aug 29.
5
Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment.肿瘤来源的外泌体、髓系来源的抑制细胞和肿瘤微环境。
J Hematol Oncol. 2019 Aug 22;12(1):84. doi: 10.1186/s13045-019-0772-z.
6
Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells.平衡癌症免疫疗法和免疫相关不良事件:调节性 T 细胞的新作用。
J Autoimmun. 2019 Nov;104:102310. doi: 10.1016/j.jaut.2019.102310. Epub 2019 Aug 15.
7
Limitations and Off-Target Effects of Tryptophan-Related IDO Inhibitors in Cancer Treatment.色氨酸相关 IDO 抑制剂在癌症治疗中的局限性和脱靶效应。
Front Immunol. 2019 Jul 30;10:1801. doi: 10.3389/fimmu.2019.01801. eCollection 2019.
8
Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment.解析肿瘤微环境中黑色素瘤与免疫细胞间的相互作用。
Semin Cancer Biol. 2019 Dec;59:236-250. doi: 10.1016/j.semcancer.2019.08.002. Epub 2019 Aug 9.
9
Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis.缺氧诱导的 MICA 脱落和 HIF1A 介导的胰腺癌细胞对 NK 细胞的免疫逃逸:circ_0000977/miR-153 轴的作用。
RNA Biol. 2019 Nov;16(11):1592-1603. doi: 10.1080/15476286.2019.1649585. Epub 2019 Aug 12.
10
miR-448 targets IDO1 and regulates CD8 T cell response in human colon cancer.miR-448 靶向 IDO1 并调节人结肠癌中的 CD8 T 细胞反应。
J Immunother Cancer. 2019 Aug 7;7(1):210. doi: 10.1186/s40425-019-0691-0.